Background: Skeletally immature children with a primary malignant
tumor in the distal end of the femur are candidates for limb-salvage surgery;
however, functional impairment due to subsequent limb-length discrepancy must
be considered. Our aim was to evaluate the long-term clinical outcome of limb
salvage in patients with a sarcoma of the distal end of the femur who were
eleven years old or less, focusing on limb-length discrepancy and
complications.
Methods: The cases of forty children were retrospectively reviewed
in a multicenter study based on the responses to a questionnaire. Twenty-eight
patients had had endoprosthetic reconstruction, and twelve had had biological
reconstruction. Functional evaluation was based on the Musculoskeletal Tumor
Society scoring system, with numerical values from 0 to 5 points assigned for
each of the following six categories: pain, function, emotional acceptance,
use of supports, walking ability, and gait. These values were added, and the
functional score was presented as a percentage of the maximum possible score.
Limb-length discrepancy was measured with orthoroentgenograms. Complications
and their treatment were analyzed. Patient survival and the survival of the
reconstructions were analyzed with use of the Kaplan-Meier method.
Results: Seven patients died and thirty-three remained alive, for a
survival rate of 82% at ten years postoperatively. For the surviving patients,
the mean follow-up periods (and standard deviations) were similar for the
twenty-two who had endoprosthetic reconstruction (13.2 ± 3.9 years) and
the eleven who had biological reconstruction (10.4 ± 4.4 years). All
patients had reached skeletal maturity. The mean final functional score was
74% ± 18% in the endoprosthetic reconstruction group and 68% ±
17% in the biological reconstruction group (p = 0.37). For the nineteen
patients who underwent limb-lengthening, the mean functional score increased
significantly from 65% ± 21% before the procedure to 81% ± 11%
after the lengthening (p = 0.0016). There were five early and twenty-eight
late complications. In the endoprosthetic reconstruction group, the most
frequent complications were deep infection and aseptic loosening. In the
biological reconstruction group, the most frequent complications were implant
breakage and nonunion. Revision surgeries were required in seventeen patients,
including five who had an amputation. The rate of survival of the
endoprosthetic reconstructions was 77% at five years and 51% at ten years
postoperatively, whereas the rate of survival of the biological
reconstructions was 46% at both five and ten years postoperatively.
Conclusions: Endoprosthetic or biological reconstructions as limb
salvage provided good functional outcome in skeletally immature children with
a malignant bone tumor of the distal aspect of the femur despite a high rate
of revisions and limb-lengthening procedures.
Level of Evidence: Therapeutic Level III. See
Instructions to Authors for a complete description of levels of evidence.